The Unseen Threads in Global Health’s Crisis Fabric

The world still grapples with the aftermath of COVID-19, yet another viral threat looms – hantavirus and Ebola outbreaks. In response, the Coalition for Epidemic Preparedness Innovations (CEPI) has been working to mitigate these risks through its ambitious “100 days” mission.

Launched in 2021, CEPI’s objective is to develop a vaccine against novel pathogens within 100 days of their genome being sequenced. This goal may seem daunting, but it’s essential for preventing devastating outbreaks that have ravaged communities and economies in the past. The hantavirus outbreak on a cruise ship has already spread to over 20 countries, while the Ebola Bundibugyo outbreak in the Democratic Republic of Congo claimed 131 lives.

CEPI’s efforts involve more than just developing new technologies; they also focus on fostering global cooperation and investment in preparedness. At the World Health Assembly in Geneva last month, CEPI chair Jane Halton emphasized the need for collective action to secure the future against potential pandemic threats. “We now have the chance, and I would say the responsibility, to change what happens next,” she said.

The “100 days” mission is built on several key pillars: knowledge-sharing among experts, stress-testing vaccine development, and establishing a global network of manufacturing facilities that can be quickly activated in response to an outbreak. The partnership between CEPI and pharmaceutical companies like Moderna has already yielded results – the mRNA vaccine manufacturing facility in Oxfordshire will serve both the UK and provide a potential hub for future pandemics.

However, despite progress, the funding landscape remains a significant challenge. CEPI estimates that it needs $2.5 billion to push forward with its plans. While commitments from governments like Singapore and the European Union are welcome steps, more is needed to achieve CEPI’s ambitious goals.

As the world struggles to make sense of these outbreaks, one thing becomes clear: global health security requires investment, cooperation, and a shared commitment to preparedness. The lessons of COVID-19 must be applied to these new challenges, including investing in research, manufacturing capacity, and international coordination.

What does it mean for societies to invest in their collective security? Halton’s words – “Everyone is investing in this collective security, every political leader in this room” – highlight a subtle shift from the language of donors and benefactors to one of investors and partners. This reflects a deeper recognition of the interconnectedness of global health challenges.

The road ahead will be long and arduous. As we confront these complex threats, it’s essential to remember that preparedness involves more than just developing new technologies or vaccines; it also requires building trust, fostering cooperation, and recognizing our shared humanity in the face of uncertainty.